1: \begin{abstract}

2: {This paper presents a mathematical model for tumour-immune response interactions in the perspective of immunotherapy by immune checkpoint inhibitors ({\it ICI}s). The model is of the nonlocal integro-differential Lotka-Volterra type, in which heterogeneity of the cell populations is taken into account by structuring variables that are continuous internal traits (aka {\it phenotypes}) present in each individual cell. These represent a lumped ``aggressiveness'', i.e., for tumour cells, malignancy understood as the ability to thrive in a viable state under attack by immune cells or drugs - which we propose to identify as a potential of de-differentiation -, and for immune cells, ability to kill tumour cells, in other words anti-tumour efficacy. We analyse the asymptotic behaviour of the model in the absence of treatment. By means of two theorems, we characterise the limits of the integro-differential system under an {\it a priori} convergence hypothesis. We illustrate our results with a few numerical simulations, which show that our model reproduces the three $E$s of immunoediting: elimination, equilibrium, and escape. Finally, we exemplify the possible impact of {\it ICI}s on these three {\it E}s.}

3: \end{abstract}

4: